Reckitt to pay $1.4 billion to end U.S. opioid addiction treatment probes
(Reuters) – Reckitt Benckiser has agreed to pay up to $1.4 billion to resolve U.S. claims that its former pharmaceuticals business Indivior before it was spun out of the company…